Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | ANO1 | Q5XXA6 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | MMP1 | P03956 | 2/20 | 0.46 |
| ▸ | MMP2 | P08253 | 2/20 | 0.46 |
| ▸ | MMP9 | P14780 | 2/20 | 0.46 |
| ▸ | NLRP3 | Q96P20 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5164495 | 0.89 | NLRP3 (0.56) | KMT2AMEN1NLRP3ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL5163148 | 0.88 | NLRP3 (0.55) | KMT2AMEN1MAPTNLRP3ALDH1A1 | |
| SCHEMBL5162082 | 0.85 | GAA (0.54) | KMT2AMEN1SMN1; SMN2ANO1MAPT | |
| SCHEMBL3815239 | 0.85 | CYP1A2 (0.53) | KMT2AMEN1NLRP3 | |
| SCHEMBL5159531 | 0.84 | NLRP3 (0.54) | KMT2AMEN1SMN1; SMN2ANO1MAPT | |
| SCHEMBL5162730 | 0.84 | KCNJ5 (0.61) | KMT2AMEN1ANO1MAPTTRPV1 | |
| SCHEMBL5165552 | 0.84 | NLRP3 (0.54) | KMT2AMEN1SMN1; SMN2NLRP3KDM4E | |
| SCHEMBL5162624 | 0.84 | NLRP3 (0.57) | KMT2AMEN1SMN1; SMN2ANO1MAPT | |
| SCHEMBL5162086 | 0.82 | ALDH1A1 (0.61) | KMT2AMEN1SMN1; SMN2MAPTTRPV1 | |
| SCHEMBL5163021 | 0.82 | CYP1A1 (0.47) | KMT2AMEN1MAPTTRPV1NLRP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070067922-A1 | 4-Aminophenol derivatives and colorants comprising these compounds | PROCTER & GAMBLE COMPANY, THE | 2007-03-29 | — | — | US | claimed |
| EP-1762218-A1 | 4-aminophenol derivatives and colorants comprising these compounds | Wella Aktiengesellschaft (DE) | 2007-03-14 | — | — | EP | claimed |
| WO-2007026313-A2 | 4-AMINOPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2007-03-08 | — | — | WO | claimed |
| US-20070067922-A1 | 4-Aminophenol derivatives and colorants comprising these compounds | PROCTER & GAMBLE COMPANY, THE | 2007-03-29 | — | — | US | disclosed |
| EP-1762218-A1 | 4-aminophenol derivatives and colorants comprising these compounds | Wella Aktiengesellschaft (DE) | 2007-03-14 | — | — | EP | disclosed |
| WO-2007026313-A2 | 4-AMINOPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2007-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070067922-A1 | 4-Aminophenol derivatives and colorants comprising these compounds | KRT18, S100A4, CKAP4 | KMT2A 1287/4885MEN1 4874/4885SMN1; SMN2 4622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.